The Science behind RejuvStem

You are eligible as long as you have a pre-approved illness or physical condition where stem cells have proven to be of clinical benefit. During your complimentary medical assessment with our physician, we will discuss the details of your eligibility.

RejuvStem is recognized as one of Mexico’s leading regenerative medical centers. Our Guadalajara and Cancun locations offer easy access for international patients, adhering to the highest international standards and GMP. 

Strategically located, Guadalajara has a number of non-stop flights, making travel painless for our patients from the mountainous and western regions of the USA and Canada. 

Cancun, a paradise of endless beaches, is a worldwide destination with a number of nonstop flights from the USA, Canada, and Europe. Both locations are equipped with expert clinicians and our licensed, COFEPRIS-certified laboratories are on-site to easily administer the most premium cells.

First, no professional and reputable medical facility can guarantee any specific outcome. Every case is different, and it depends on how the patient’s body responds to the treatment. For this reason, it is of great importance for our specialists to know all about your particular case before deciding if you are a good candidate for a stem cell treatment. 

This involves the study of all your medical records, laboratory results, and other types of information that will help the specialist make the most accurate decision. Not all patients qualify, and we will only treat patients whom we feel will truly benefit from our therapy. Our recommendations are based on published studies and clinical experience with previous patients. 

The goal is to improve health and quality of life through the use of stem cells. The procedure is minimally invasive and could help achieve the desired effect by supporting another medical treatment or as a unique treatment. 

In most cases, procedures are made on the same day unless the physician has health concerns for a previously diagnosed illness that can be kept for observation and monitoring. Our facility is conveniently located inside a fully functioning, fully certified and accredited private hospital, which makes any observation and monitoring very simple.

In general, cell therapy with allogenic Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs) has been tolerated in other research studies on many other pathology treatments, diseases, and/or disorders on an international level. There is no immune response or rejection with these cells. About 30% of our patients do experience mild flu-like symptoms, a low-grade fever, and body aches for 24-48 hours after treatment. 

Although it is possible that an adverse effect could be present with any medical procedure, we take every possible measure to avoid issues.